: vimarsana.com

TOKYO (Reuters) -- Drugmaker Merck will pay Daiichi Sankyo $5.5 billion to jointly develop three of the Japanese drugmaker's candidate cancer drugs, t

Related Keywords

Tokyo , Japan , Japanese , Daiichi Sankyo , Tina Banerjee , Astrazeneca , Daiichi , Sankyo , Merck , Sign , 95bn , Deal , Develop , Cancer , Therapies ,